Therapeutic Efficacy of YH35324 on FcεRIα-Mediated Mast Cell/Basophil Activation
YH represents a new therapeutic agent for IgE-mediated allergic disease. Further studies are needed to evaluate its additional effects on the FcεRIα-mediated autoimmune mechanism.
Authors
- Sae Young Lee (ORCID: https://orcid.org/0009-0006-6939-0045)
- J.G. Kim
- Eun‐Mi Yang (ORCID: https://orcid.org/0000-0001-8371-3513)
- Min Sook Ryu (ORCID: https://orcid.org/0000-0002-9807-7895)
- Jae-Hyuk Jang (ORCID: https://orcid.org/0000-0002-4225-7117)
- Young‐Min Ye (ORCID: https://orcid.org/0000-0002-7517-1715)
- Hae‐Sim Park (ORCID: https://orcid.org/0000-0003-2614-0303)
Institutions
- Yuhan (South Korea) (KR)
- Ajou University (KR)
Publication Details
- Journal
- Allergy Asthma and Immunology Research
- Published
- 2025-01-01
- DOI
- https://doi.org/10.4168/aair.2025.17.2.181
- Citations
- 4
- Primary Topic
- Mast cells and histamine
- Type
- article
- Field-Weighted Citation Impact
- 3.19
Funders
- Yuhan
- Ajou University
- Korea Health Industry Development Institute